Erythropoietin (epo) is the primary regulator of the rate of red blood cell formation in mammals. Because it is formed in the kidney and acts on the bone marrow, its action is classically endocrine. We have shown by PCR that marrow cells contain epo mRNA and that antisense oligodeoxynucleotides, to both epo and its receptor, act on multipotent hematopoietic cells to cause a decrease in mixed erythr0id:nonerythroid colonies. The antisense oligonucleotides also cause an increase in mixed nonerythroid colonies with no effect on HE EFFECX of erythropoietin (epo) on erythroid T differentiation has long been known to be an exocrine one because, in vivo, it is formed largely in the kidney' and acts on precursor cells of the marrow. It is widely accepted that epo acts primarily on cells late in the erythroid pathway to induce terminal differentiation and survival of these cells,2 although some evidence has been adduced and hypotheses developed suggesting that epo can act on earlier cells and may play a role in the commitment of cells to the erythroid path~ay.'.~ For several years we have been studying lines of mouse spleen cells, transformed by the murine leukemia virus, that produce and secrete epo constitutively and that are erythroid in nature because treatment with hemin or butyrate leads to hemoglobin synthesis?s6 The existence of cells with hematopoietic characteristics, but that also express the epo gene, leads to the hypothesis that they might be examples of cells with autocrine regulation.' In this report we extend the general idea of autocrine regulation to normal erythropoiesis. We examined bone marrow for the presence of epo mRNA and studied the effects of antisense oligonucleotides on early colony-forming cells with results that strongly suggest an internal autocrine mechanism during normal bone marrow erythropoiesis.
T differentiation has long been known to be an exocrine one because, in vivo, it is formed largely in the kidney' and acts on precursor cells of the marrow. It is widely accepted that epo acts primarily on cells late in the erythroid pathway to induce terminal differentiation and survival of these cells,2 although some evidence has been adduced and hypotheses developed suggesting that epo can act on earlier cells and may play a role in the commitment of cells to the erythroid path~ay.'.~ For several years we have been studying lines of mouse spleen cells, transformed by the murine leukemia virus, that produce and secrete epo constitutively and that are erythroid in nature because treatment with hemin or butyrate leads to hemoglobin synthesis?s6 The existence of cells with hematopoietic characteristics, but that also express the epo gene, leads to the hypothesis that they might be examples of cells with autocrine regulation.' In this report we extend the general idea of autocrine regulation to normal erythropoiesis. We examined bone marrow for the presence of epo mRNA and studied the effects of antisense oligonucleotides on early colony-forming cells with results that strongly suggest an internal autocrine mechanism during normal bone marrow erythropoiesis.
MATERIALS AND METHODS

RNA Extraction
Bone marrow cells obtained as described below were washed twice in cold phosphate-buffered saline (PBS). Total RNA was extracted by the guanidinium/CsCl method? RNA was dissolved in diethyl pyrocarbonate-treated glass-distilled water at a concentration of 1 to 5 kg/kL. The same methods were used for marrow cells from normal human volunteers, except for doing a preliminary separation by Ficoll-Hypaque (Pharmacia LKB Biotechnology, Piscataway, NJ) gradient centrifugation and using the cells collected at the interface. The mixture was incubated for 10 minutes at 23°C followed by 1 hour at 42°C. Reverse transcriptase was inactivated and the erythroid burst formation. Sense oligonucleotides have no effect. The antisense suppression is not due to adherent cells, cycling late differentiated cells or lymphocytes, and not reversed by exogenous epo. We conclude that normal erythroid differentiation may have an early phase that is dependent on an internal autocrine mechanism involving epo and its receptor. 6 1991 by The American Society of Hematology.
cDNA Synthesis and PoIymerase Chain Reaction (PCR)
RNAIDNA hybrid separated by heating to 95°C for 5 minutes and then quickly chilling on ice.
To the solution containing cDNA, 80 p.L of 1X PCR buffer containing 40 pmol of the upstream primer and 2 U of Taq polymerase (Perkin Elmer Cetus, Norwalk, CT) were added. After layering with 100 pL of mineral oil the cDNA was amplified using a thermocycler (Perkin Elmer Cetus). Forty cycles were used, with each cycle consisting of denaturation at 95°C for 2 minutes, annealing at 60°C for 2 minutes, and extension at 72°C for 1 minute.
The amplified cDNA was loaded on to a 1% agarose gel, and after electrophoresis and photography, the cDNA was transferred onto GeneScreen Plus (Dupont Co New England Nuclear Products, Boston, MA) by a standard Southern Blot technique? For probing the filters, a mixture of 1.0 kb and 1.2 kb PstI restriction fragment of the cloned mouse epo gene" subcloned into plasmid pUC19 was used.' For human marrow the probe was a monkey epo cDNA." The probes were labeled by nick translation to a specific activity of about 10' cpm/pg of DNA using a nick translation kit and "P CTP (> 400 Ci/mmol) (Amersham, Arlington Heights, IL). The filter was prehybridized in 20 mL of prehybridization solution (50% formamide, 10% dextran sulfate, 1% sodium dodecyl sulfate [SDS] , and 1 mol/L NaCI) for 1 hour at 42"C, and then 1 mL of solution containing 2 x lo7 cpm of labeled probe, denatured by boiling in the presence of 200 pg of herring sperm DNA, was added and hybridization allowed to proceed for 16 hours at 42°C with constant agitation. The filter was then washed twice with 2X SSC at room temperature for 5 minutes each time, twice with 2X SSC and 1% SDS at 65°C for 30 minutes each time, and finally twice with 0.1X SSC at room temperature for 30 minutes each time. The filter was exposed to Kodak XARS x-ray film (Eastman Kodak Co, Rochester, NY) with an intensifying screen (E.I. du Pont de Nemours Co Inc, Wilmington, DE) for varying times at -70°C.
2254
HERMINE ET AL
Cell Culture
Marrow cells were flushed in a medium from the femora and tibiae of BDF-1 female mice 6 to 8 weeks old (Charles River Laboratories, Willmington, MA) or from SCID mice." In experiments using 5-fluorouracil (SFU), BDF-1 mice were injected with a single intravenous injection of 0.5 mL of 5FU (Sigma) at 150 mg/kg. Bone marrow cells were harvested at 4 days postinjection and were counted by hemocytometry.
For the study of antisense effects, bone marrow cells were harvested and resuspended to 106/mL in 70% a medium (Hazelton, Lenexa, KS) and 30% FCS (GIBCO BRL). The serum had been heated to 66°C for 45 minutes to reduce the exonuclease activity and thus increase the half-life of the oligodeoxynucleotides.
The cell suspensions (2 mL) were incubated in 35-mm suspension culture dishes (Lux Scientific, Thousand Oaks, CA). Where indicated, 150 kg of the appropriate oligodeoxynucleotides were added at zero time and 75 pg 24 hours later. Antibody and IL-3 (2 U/mL) were added at zero time, and the cells incubated at 37°C in a humidified atmosphere of 5% CO,, 95% air for 36 hours. a Medium (1 mL) was then added and the cells were harvested by gentle pipetting and centrifuged at 1,000g for 10 minutes at 4°C. Cells were resuspended in a medium at a concentration of 106 cells in 0.5 mL.
Preincubated cells ( 10S/mL) were resuspended in medium consisting of 68% a medium, 30% FCS heated at 56°C for 30 minutes, 0.8% methylcellulose (methocel A4M premium; Dow Chemical, Midland, MI), mol/L 2-mercaptoethanol (Eastman Kodak) lo-' mol/L sodium selenite (ICN Pharmaceuticals, Plainview, NY), and 2% bovine serum albumin (Armour Pharmaceuticals, Kankakee, IL). The 1-mL cell suspensions containing 1 U/mL of epo (recombinant human epo, Amgen, Inc, Thousand Oaks, CA) and 50 U/mL of recombinant murine IL-3 were plated in 35 x 10-mm dishes (Lux Scientific, Thousand Oaks, CA) and incubated in a fully humidified atmosphere of 5% CO,, 95% air for 7 or 11 days. Four replicates were plated in all experiments. The colonies were then stained in situ with benzidine according to the method of Ogawa" and scored under a dissecting microscope.
To deplete bone marrow of adherent cells, the total cell suspension was incubated in a 60-mm culture dish (Falcon; Becton Dickinson Labware, Lincoln Park, NJ) at 37°C and in 5% CO,, 95% air for 30 minutes. The nonadherent cells were removed and incubated as described previously in a second 60-mm culture dish for an additional 30 minutes and nonadherent cells were again collected.
Colonies were defined as follows: discrete aggregates of 50 or more cells were scored as colonies and erythroid bursts (BFU-E) were composed entirely of benzidine positive cells. Mixed erythroid nonerythroid (Enon-E) colonies were composed of benzidine positive cells and nonerythroid cells, mostly monocytes and granulocytes. Mixed nonerythroid (non-E) colonies were composed of two or more different non-E cell types with no benzidine-positive cells.
Fifteen colonies, nine mixed Enon-E and six mixed non-E, were plucked from dishes by micropipetting under a dissecting microscope. The cells were resuspended in a medium plus 30% FCS, applied to slides using a cytocentrifuge and stained by WrightGiemsa. The slides were scored for erythrocytic (E), monocytic (M), granulocytic (G), and lymphocytelike (L) cells. Table 2 shows the distribution of cell type as percent of those scored for each colony.
Statistical significance was calculated by two-tailed t-test using
Abstat software (Anderson-Bell Parker Co). The data in the tables for total colonies are the means of the sums of the individual colonies.
Preparation of Oligodeoxynucleotides
The synthetic oligomers were synthesized on an Applied Biosystems 380B DNA synthesizer (Applied Biosystems, Inc, Foster City, CA).
PCRprimers. The sequences for the upstream and downstream primers were based on the mouse epo gene sequence'"12 and were within exons I1 and V respectively. Upstream: S'CTCTGGGCCTC-CCAGTC 3'; downstream: S'TG'ITCGGAGTGGAGCAG 3'. For human bone marrow RNA the primers were: upstream: 5'CTGCAGmGAATGAGAATATCAC 3' from exon 3; downstream: S'TGGAGTAGACTCGGAAGAGTTTGC 3' from exon 5.13
Epo senselantisense oligodeoxynucleotides. These oligodeoxynucleotides were based on the mouse gene sequence: (1) 
Antibodies
We used a polyclonal, monospecific, neutralizing anti-epo, obtained from Genzyme (Boston, MA), at a dilution of 1:100. The antibody (1 pL) was incubated for 36 hours at 37°C with 100 mU of epo (1 pL) and 100 e L of ct medium with 30% fetal calf serum (FCS) treated at 66°C for 45 minutes. After incubation aliquots of the solution were assayed for epo activity by the rat bone marrow cell method.I5 The results (Table 1) show that this antibody neutralizes about 67 mU of epo activity per microliter under the conditions used for a later experiment.
epo Determination
In order to assay for epo secretion, bone marrow cells were collected and counted as described below. The cells were resuspended to a final concentration of 8 x 106/mL. Five milliliters of cell suspension was incubated in T-25 flasks (Nunc Inc, Naperville, IL) with 2 U/mL of murine recombinant interleukin-3 (IL-3) with or without 200 emol/L hemin (Sigma Chemical Co, St Louis, MO) for 70 hours at 37"C, 5% C 0 2 at 1%, or 21% 0,. The cell supernatants were collected and concentrated in a Centricon filtration unit (Amicon, Danvers, MA, MW cut-off l0,OOO) for 2 hours at 6,500 rpm to 1.5 mL and assayed for epo by radioimmunoassay(RIA).16 
RESULTS
The Prrsence ofepo mRN.4 in Bone M a m w Celk
Normal crythroid tissuc, whcn cxamincd by the Northcrn blot tcchniquc, shows no detectable cpo mRNA (data not shown), so wc uscd thc PCR mcthod to dctcrminc whcthcr marrow cclls wcrc trulv devoid of this message. Wc uscd a downstrcam primcr to initiatc cDNA svnthcsis and amplificd thc cpo cDNA using both thc downstrcam and an upstrcam primcr. Thc product was analyzed hy Southcrn hlotting using a mouse cpo probc. two primcrs. Because thc upstrcam and downstrcam primcrs arc dcrivcd from cxons I1 and V. rcspcctivcly, 0.41 kb is thc cxpcctcd sizc: an amplification product duc to contaminating DNA containing thc cpo scqucncc would yicld a fragmcnt of about 2 kb. No cpo mRNA was dctcctcd by this mcthod whcn RNA or rcvcrsc transcriptase was omittcd from thc rcaction (data not shown) or when RNA extracted from thc lymphocytic cell line D10 was uscd (lanc 1). Nor did wc find any cpo mRNA by this procedure with RNA from mousc hcart. skclctal musclc. lung, six T t c l l cloncs. and a B-ccll linc. Thcsc data show that cpo mRNA is present in somc of thc cells of normal mouse honc marrow.
Human bonc marrow cDNA was prcparcd. amplified. and analyzed by Southcrn blotting with a monkcy cpo cDNA prohc (Fig 2) . Wc found a 0.34-kh fragmcnt corrcsponding to thc calculatcd sizc of thc cpo c D S A amplified bctwccn thc two primcrs, indicating that cpo mRNA is prcscnt in normal human marrow, as it is in mousc marrow.
indicated on the left side of the figure.
Rccausc thc primcrs uscd wcrc within cxons
distinguish between an amplified contaminant containing DNA that would be 1.1 kb in size and the amplified mRNA-derived cDNA at 0.34 kb. This difference is seen in Fig 2A, lane 2 (RNA with DNA contaminant), versus lane 3, RNA alone. Lane 1 shows no signal when RNA was absent in the mixture used for cDNA synthesis and amplification. Similar negative results with respect to the detection of epo mRNA were obtained when reverse transcriptase was omitted from the reaction mixtures.
When RNA samples from the human lymphoid cell line HP-1 or the T-cell line, SLB P54, were used we found no epo cDNA after amplification (Fig 2B, lanes 1 and 2) . Three other preparations from different marrow samples are illustrated in lanes 3, 4, and 5. To ensure that these negative results were not due to faulty cDNA synthesis and/or amplification, we used the same RNA preparation from the HP-1 cells, but with p-actin primers, and found ample evidence of actin cDNA amplification (Fig 3) .
If this normal, endogenous epo mRNA is translated and if the epo is secreted, it is at a level not detectable by the RIA for epo we routinely use.I6 Mouse marrow cells at 8 x 106/mL were incubated for 72 hours in medium containing IL-3, and the supernatant was collected, concentrated fourfold, and assayed. No epo was detected and we can detect about 0.6 fmol of added epo. Because of reports that hemin could cause the appearance of epo-independent erythroid colonies2' and because of the effect of hypoxia on epo synthesis, we assayed supernatants from marrow cells exposed to hypoxia (1% and 5% oxygen) or hemin (0.2 mmol/L); they were also devoid of detectable epo (data not shown).
Effects of Antisense Oligodeoxynucleotides on Hematopoiesk
The presence of epo mRNA without any detectable epo in bone marrow is compatible with the hypothesis of internal autocrine regulation but does not provide definitive evidence. Therefore, we studied the effects of epo antisense oligonucleotides on hematopoietic cell differentiation. We used 18 mer oligodeoxynucleotides based on the first codons of mouse exons I and 11; these oligonucleotides were chosen because for most of the antisense effects reported, inhibition was maximal when the antisense oligonucleotide was directed at the 5' end of the mRNA.2' The medium in which the marrow cells were preincubated with the antisense and sense oligonucleotides contained FCS preheated at 66°C for 45 minutes to minimize nuclease action." It also contained IL-3 to ensure pluripotent cellU and burst-forming unit erythroid progenitors (BFU-E) survivalz4; in its absence there was massive cell death during the 36-hour preincubation period (data not shown). After preincubation the cells were plated in methyl cellulose with both added IL-3 and epo and incubated for 7 or 11 days, after which BFU-E, mixed Enon-E, and mixed non-E colonies were scored. The results of one typical experiment, out of three done under these conditions, are shown in Table 3 . After 7 days of culture BFU-E represented 8% to 12% of the total colonies scored and there was no effect of either the antisense or sense oligonucleotides on these precursor cells. In contrast, the progenitors of mixed Emon-E colonies were reduced 65% with the anti-exon I and 80% with anti-exon 11, with no effect of the sense oligonucleotides. Concomitantly the mixed non-E colonies were increased by the antisense oligonucleotides to the same extent as the decrease noted previously, so that the total number of colonies was not affected. At 11 days of culture there were, asexpected, no erythroid bursts and only the two types of mixed colonies were scored. Here too, the exons I and I1
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From antisense oligonucleotides caused a significant decrease (80%) in mixed E:non-E colonies, and the sense oligonucleotides had no effect. These data indicate, strongly, that the presence and function of epo mRNA must play a role in the differentiation of those cells that are the precursors of mixed E:non-E colonies and, perhaps indirectly, on those cells that are the precursors of the mixed non-E colonies, because both types of mixed colonies might be derived from the same precursor cell."
Studies Concerning the Cells Affected by the Antisense Oligonucleotides
Because marrow cells are so heterogeneous, and because the properties of the precursors in question are not known and separation methods for those cells are not available, we used alternative approaches to study the nature of the cells affected. In the first we used marrow cells from mice treated with 5FU as a means of eliminating an effect on later precursors or on rapidly cycling cells, because 5FU is known to eliminate those cells from the marrow.z Four days after 5FU injection, we harvested marrow cells and repeated the antisense experiments as previously described. The results ( Table 4) show essentially the same suppressive effect of antisense oligonucleotides on mixed Emon-E colonies, the same increase in mixed non-E colonies, and no effect on the very small number of BFU-E. Similarly, the sense oligonucleotides had no effect. These data indicate that the effect of the antisense oligonucleotide is on early precursor cells.
Other cells of the marrow have been eliminated as possibly being involved in the antisense effect. Table 5 shows that depletion of adherent cells from normal marrow does not alter the suppressive effect of the antisense oligonucleotides. Another similar experiment using marrow from SCID mice (Table 6) shows that functional T and B cells are not required for the antisense effect.
Is External epo Involved in the Antisense Effect?
It is possible that after reducing the number of adherent cells, lymphocytes, or 5FU-sensitive cells, the remaining cells might produce enough epo to induce erythroid commitment during the preincubation period and thereby cause a decrease in mixed E:non-E colonies. If this were the case, and because any epo so produced is at an undetectably low 
Values are the means f SD of four replicate cultures with percent of total in parentheses. Bone marrow cells were extracted 4 days after 5FU injection and 10' cells were plated per dish. Colonies were scored on day 10.
'Significance at P < .05 when compared with control. concentration, such an effect would be expected to increase with increased epo. Therefore, we added epo to the preincubation mixture and repeated the experiment. The results (Table 7) show that epo addition did not abrogate the suppressive effect of the antisense oligonucleotides or cause a suppressive effect of either the control or the sense oligonucleotides.
In another test of whether extracellular epo might have an effect on the steps leading to erythroid commitment by early precursor cells, we preincubated the cells for 36 hours with a neutralizing anti-epo and with IL-3, washed the cells, and cultured them in the presence of epo. We found no effect of the antibody on mixed E:non-E colonies, mixed non-E colonies, or on BFU-E at 7 days (Table 8 ). The results of these experiments also indicate that the antisense oligonucleotides did not cause suppression of mixed E:non-E colonies by inhibiting epo production by some "accessory" cell.
In an analogous, complementary experiment we compared the effects on colony formation of sense and antisense oligonucleotides corresponding to the epo receptor. In this experiment (Table 9) there was a significant increase in total colonies at both days 7 and 11 when the antisense oligonucleotide was present. More importantly, there was a highly significant decrease (76% at day 7 and 64% at day 11) in mixed Emon-E colonies and a significant increase in mixed non-E (32% at day 7) colonies due to the receptor antisense, and again no change in erythroid bursts. The sense oligonucleotide had no effect on the percentage of total for each colony type.
DISCUSSION
The accepted view that the control of the rate of erythropoiesis by epo is mediated solely by an exocrine process in which epo formed by kidney or fetal liver cells acts on cells committed to the erythroid pathway, must, in the light of our findings reported here, be modified. The formation of colonies that contain erythroid and nonerythroid cells from multipotent precursor cells is significantly suppressed by specific epo and epo receptor antisense oligonucleotides. The sequences of the two epo antisense oligonucleotides used were chosen to interact specifically with epo sequences, most probably at the level of mRNA." The possibility that the antisense oligonucleotide reacted with some mRNA other than that for epo is minimized by the fact that the epo sequence has no homology in the data bank,'"' and by the fact that an oligonucleotide length of 18 nucleotides is sufficient to uniquely define sequence specificity.= The suppressive effects that we report here implicate epo mRNA and the epo receptor mRNA in the differentiation of pluripotent precursor cells, an effect not found when the corresponding sense oligonucleotides were used.
The presence of epo mRNA in bone marrow cells and the epo antisense results provide evidence, significantly strengthened by the results with the epo receptor antisense oligonucleotide, for the autocrine hypothesis. These findings suggest that an intracellular interaction between epo and its receptor may play a role in early hematopoiesis.
Although the results of the antisense experiments indicate that epo mRNA is involved in erythroid differentiation at the level of multipotent precursor cells, it was important to rule out some of the more obvious possibilities that the effect might be indirectly mediated by some accessory cells, eg, by macrophages forming ep0,2~ although this is still open to debate?' Our data show that neither late, cycling precursor cells, macrophages and other adherent cells, nor lymphocytes are involved in the suppression of erythroid differentiation by epo antisense oligonucleotides.
It might be argued that mixed E:non-E colony formation is reduced because epo secreted by some bone marrow cells acts to induce erythroid differentiation, thereby decreasing mixed colony formation. If this were the case the effect of epo ought to be dose-dependent and the data in Table 7 show no effect of adding epo to the cells during the preincubation period. Similarly, neutralization of epo with antibody during the preincubation does not change mixed colony formation (Table 8 ). In addition, it is well estab- For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 
